Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Passive administration of neutralizing antibodies (Abs) is an attractive strategy for the control of gastrointestinal infections. However, an unanswered practical concern is the need to assure the stability of sufficient amounts of orally administered neutralizing Abs against intestinal pathogens (e...
Main Authors: | Yoshikazu Yuki, Fanglei Zuo, Shiho Kurokawa, Yohei Uchida, Shintaro Sato, Naomi Sakon, Lennart Hammarström, Hiroshi Kiyono, Harold Marcotte |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/63 |
Similar Items
-
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
by: Sarah Kalusche, et al.
Published: (2020-12-01) -
Development of a Nanobody-Based Lateral Flow Immunoassay for Detection of Human Norovirus
by: Sylvie Y. Doerflinger, et al.
Published: (2016-10-01) -
Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus
by: Ai Sasou, et al.
Published: (2021-02-01) -
Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies
by: Jing Zuo, et al.
Published: (2017-10-01) -
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
by: Peter Bannas, et al.
Published: (2017-11-01)